Cargando…

Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study

BACKGROUND: Proinflammatory biomarkers levels are increased among patients with cardiovascular disease, and it is known that both the presence of insulin resistance and diet may influence those levels. However, these associations are not well studied among patients with established cardiovascular di...

Descripción completa

Detalles Bibliográficos
Autores principales: Bersch-Ferreira, Ângela Cristine, Sampaio, Geni Rodrigues, Gehringer, Marcella Omena, Torres, Elizabeth Aparecida Ferraz da Silva, Ross-Fernandes, Maria Beatriz, da Silva, Jacqueline Tereza, Torreglosa, Camila Ragne, Kovacs, Cristiane, Alves, Renata, Magnoni, Carlos Daniel, Weber, Bernardete, Rogero, Marcelo Macedo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822607/
https://www.ncbi.nlm.nih.gov/pubmed/29466985
http://dx.doi.org/10.1186/s12937-018-0342-1
_version_ 1783301723291385856
author Bersch-Ferreira, Ângela Cristine
Sampaio, Geni Rodrigues
Gehringer, Marcella Omena
Torres, Elizabeth Aparecida Ferraz da Silva
Ross-Fernandes, Maria Beatriz
da Silva, Jacqueline Tereza
Torreglosa, Camila Ragne
Kovacs, Cristiane
Alves, Renata
Magnoni, Carlos Daniel
Weber, Bernardete
Rogero, Marcelo Macedo
author_facet Bersch-Ferreira, Ângela Cristine
Sampaio, Geni Rodrigues
Gehringer, Marcella Omena
Torres, Elizabeth Aparecida Ferraz da Silva
Ross-Fernandes, Maria Beatriz
da Silva, Jacqueline Tereza
Torreglosa, Camila Ragne
Kovacs, Cristiane
Alves, Renata
Magnoni, Carlos Daniel
Weber, Bernardete
Rogero, Marcelo Macedo
author_sort Bersch-Ferreira, Ângela Cristine
collection PubMed
description BACKGROUND: Proinflammatory biomarkers levels are increased among patients with cardiovascular disease, and it is known that both the presence of insulin resistance and diet may influence those levels. However, these associations are not well studied among patients with established cardiovascular disease. Our objective is to compare inflammatory biomarker levels among cardiovascular disease secondary prevention patients with and without insulin resistance, and to evaluate if there is any association between plasma fatty acid levels and inflammatory biomarker levels among them. METHODS: In this cross-sectional sub-study from the BALANCE Program Trial, we collected data from 359 patients with established cardiovascular disease. Plasma fatty acids and inflammatory biomarkers (interleukin (IL)-1β, IL-6, IL-8, IL-10, IL-12, high sensitive C-reactive protein (hs-CRP), adiponectin, and tumor necrosis factor (TNF)-alpha) were measured. Biomarkers and plasma fatty acid levels of subjects across insulin resistant and not insulin resistant groups were compared, and general linear models were used to examine the association between plasma fatty acids and inflammatory biomarkers. RESULTS: Subjects with insulin resistance had a higher concentration of hs-CRP (p = 0.002) and IL-6 (p = 0.002) than subjects without insulin resistance. Among subjects without insulin resistance there was a positive association between stearic fatty acid and IL-6 (p = 0.032), and a negative association between alpha-linolenic fatty acid and pro-inflammatory biomarkers (p < 0.05). Among those with insulin resistance there was a positive association between monounsaturated fatty acids and arachidonic fatty acid and adiponectin (p < 0.05), and a negative association between monounsaturated and polyunsaturated fatty acids and pro-inflammatory biomarkers (p < 0.05), as well as a negative association between polyunsaturated fatty acids and adiponectin (p < 0.05). Our study has not found any association between hs-CRP and plasma fatty acids. CONCLUSIONS: Subjects in secondary prevention for cardiovascular disease with insulin resistance have a higher concentration of hs-CRP and IL-6 than individuals without insulin resistance, and these inflammatory biomarkers are positively associated with saturated fatty acids and negatively associated with unsaturated fatty acids. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12937-018-0342-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5822607
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58226072018-02-26 Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study Bersch-Ferreira, Ângela Cristine Sampaio, Geni Rodrigues Gehringer, Marcella Omena Torres, Elizabeth Aparecida Ferraz da Silva Ross-Fernandes, Maria Beatriz da Silva, Jacqueline Tereza Torreglosa, Camila Ragne Kovacs, Cristiane Alves, Renata Magnoni, Carlos Daniel Weber, Bernardete Rogero, Marcelo Macedo Nutr J Research BACKGROUND: Proinflammatory biomarkers levels are increased among patients with cardiovascular disease, and it is known that both the presence of insulin resistance and diet may influence those levels. However, these associations are not well studied among patients with established cardiovascular disease. Our objective is to compare inflammatory biomarker levels among cardiovascular disease secondary prevention patients with and without insulin resistance, and to evaluate if there is any association between plasma fatty acid levels and inflammatory biomarker levels among them. METHODS: In this cross-sectional sub-study from the BALANCE Program Trial, we collected data from 359 patients with established cardiovascular disease. Plasma fatty acids and inflammatory biomarkers (interleukin (IL)-1β, IL-6, IL-8, IL-10, IL-12, high sensitive C-reactive protein (hs-CRP), adiponectin, and tumor necrosis factor (TNF)-alpha) were measured. Biomarkers and plasma fatty acid levels of subjects across insulin resistant and not insulin resistant groups were compared, and general linear models were used to examine the association between plasma fatty acids and inflammatory biomarkers. RESULTS: Subjects with insulin resistance had a higher concentration of hs-CRP (p = 0.002) and IL-6 (p = 0.002) than subjects without insulin resistance. Among subjects without insulin resistance there was a positive association between stearic fatty acid and IL-6 (p = 0.032), and a negative association between alpha-linolenic fatty acid and pro-inflammatory biomarkers (p < 0.05). Among those with insulin resistance there was a positive association between monounsaturated fatty acids and arachidonic fatty acid and adiponectin (p < 0.05), and a negative association between monounsaturated and polyunsaturated fatty acids and pro-inflammatory biomarkers (p < 0.05), as well as a negative association between polyunsaturated fatty acids and adiponectin (p < 0.05). Our study has not found any association between hs-CRP and plasma fatty acids. CONCLUSIONS: Subjects in secondary prevention for cardiovascular disease with insulin resistance have a higher concentration of hs-CRP and IL-6 than individuals without insulin resistance, and these inflammatory biomarkers are positively associated with saturated fatty acids and negatively associated with unsaturated fatty acids. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12937-018-0342-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-21 /pmc/articles/PMC5822607/ /pubmed/29466985 http://dx.doi.org/10.1186/s12937-018-0342-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bersch-Ferreira, Ângela Cristine
Sampaio, Geni Rodrigues
Gehringer, Marcella Omena
Torres, Elizabeth Aparecida Ferraz da Silva
Ross-Fernandes, Maria Beatriz
da Silva, Jacqueline Tereza
Torreglosa, Camila Ragne
Kovacs, Cristiane
Alves, Renata
Magnoni, Carlos Daniel
Weber, Bernardete
Rogero, Marcelo Macedo
Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study
title Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study
title_full Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study
title_fullStr Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study
title_full_unstemmed Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study
title_short Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study
title_sort association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822607/
https://www.ncbi.nlm.nih.gov/pubmed/29466985
http://dx.doi.org/10.1186/s12937-018-0342-1
work_keys_str_mv AT berschferreiraangelacristine associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT sampaiogenirodrigues associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT gehringermarcellaomena associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT torreselizabethaparecidaferrazdasilva associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT rossfernandesmariabeatriz associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT dasilvajacquelinetereza associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT torreglosacamilaragne associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT kovacscristiane associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT alvesrenata associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT magnonicarlosdaniel associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT weberbernardete associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy
AT rogeromarcelomacedo associationbetweenplasmafattyacidsandinflammatorymarkersinpatientswithandwithoutinsulinresistanceandinsecondarypreventionofcardiovasculardiseaseacrosssectionalstudy